RED-CELL AND PLATELET CONCENTRATES FROM BLOOD COLLECTED INTO HALF-STRENGTH CITRATE ANTICOAGULANT - IMPROVED MAINTENANCE OF RED-CELL 2,3-DIPHOSPHOGLYCERATE IN HALF-CITRATE RED-CELLS

被引:13
作者
FARRUGIA, A
DOUGLAS, S
JAMES, J
WHYTE, G
机构
[1] Blood Product Development Section, South Melbourne, Victoria, Red Cross Blood Bank
关键词
D O I
10.1111/j.1423-0410.1992.tb01215.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study confirms previous work suggesting equivalent in vitro properties in blood components prepared from donations collected into half-citrate preservative (HCPD) compared to components derived from donations collected into standard citrate-phosphate-dextrose (CPD) preservatives. In addition, red cell products harvested from HCPD donations showed significantly improved maintenance of pH over storage, and this was reflected in improved maintenance of intracellular 2,3-diphosphoglycerate (2,3-DPG). This effect was observed in whole blood and in red cells suspended in a phosphate-containing additive solution (Tuta AAS). Collection into HCPD also improved 2,3-DPG maintenance in red cell concentrates processed following an 18-hour hold at 22-degrees-C. These improvements were less pronounced in red cells suspended in a non-phosphate-containing medium (Fenwal Adsol) in which a higher pH was maintained even in units collected in CPD. Platelets harvested from HCPD blood and suspended in plasma showed equivalent quality to platelets from standard donations. Some deterioration of platelet properties was observed when HCPD platelets were stored in a non-citrate synthetic medium. Together with data indicating improved coagulation factor stability, these results suggest that collection into HCPD improves stored blood quality and may also allow logistical benefits in blood component preparation.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 40 条
[31]  
MURPHY WG, 1991, TRANSFUSION MED S2, V1, P67
[32]   PREPARATION OF LEUKOCYTE-POOR PLATELET CONCENTRATES FROM BUFFY COATS .2. LACK OF EFFECT ON STORAGE OF DIFFERENT PLASTICS [J].
PIETERSZ, RNI ;
REESINK, HW ;
DEKKER, WJA .
VOX SANGUINIS, 1987, 53 (04) :208-213
[33]   STUDIES ON THE PROCUREMENT OF BLOOD-COAGULATION FACTOR-VIII INVITRO STUDIES ON BLOOD COMPONENTS PREPARED IN HALF-STRENGTH CITRATE ANTICOAGULANT [J].
PROWSE, C ;
WATERSTON, YG ;
DAWES, J ;
FARRUGIA, A .
VOX SANGUINIS, 1987, 52 (04) :257-264
[34]   INVIVO EFFECTIVENESS OF A HIGH-YIELD FACTOR-VIII CONCENTRATE PREPARED IN A BLOOD-BANK [J].
ROCK, G ;
SMILEY, RK ;
TITTLEY, P ;
PALMER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (05) :310-313
[35]   EFFECT OF CITRATE ANTICOAGULANTS ON FACTOR-VIII LEVELS IN PLASMA [J].
ROCK, G ;
TITTLEY, P ;
FULLER, V .
TRANSFUSION, 1988, 28 (03) :248-252
[36]   PLATELET STORAGE IN A PLASMA-FREE MEDIUM [J].
ROCK, G ;
SWENSON, SD ;
ADAMS, GA .
TRANSFUSION, 1985, 25 (06) :551-556
[37]   IMPROVED YIELDS OF FACTOR-VIII FROM HEPARINIZED PLASMA [J].
ROCK, GA ;
CRUICKSHANK, WH ;
TACKABERRY, ES ;
PALMER, DS .
VOX SANGUINIS, 1979, 36 (05) :294-300
[38]   AUTOMATION OF ROUTINE COAGULATION-TESTING USING A RANDOM-ACCESS CENTRIFUGAL ANALYZER [J].
ROWELL, JA ;
ELMS, MJ ;
YOUNG, J ;
BUNCE, IH .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 89 (03) :347-352
[39]  
SHERWOOD WC, 1980, TRANSFUSION, P644
[40]  
WEISS HJ, 1965, THROMB DIATH HAEMOST, V14, P32